My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 736

    1.

    Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue.

    Targher G, Bonadonna RC, Alberiche M, Zenere MB, Muggeo M, Bonora E.

    Diabetes Care. 2001 Nov;24(11):1961-6.PMID: 11679465 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes.

    Blüher M, Unger R, Rassoul F, Richter V, Paschke R.

    Diabetologia. 2002 Feb;45(2):210-6.PMID: 11935152 [PubMed - indexed for MEDLINE]Related articles

    3.

    Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia.

    Turhan H, Erbay AR, Yasar AS, Aksoy Y, Bicer A, Yetkin G, Yetkin E.

    Coron Artery Dis. 2005 Feb;16(1):45-50.PMID: 15654200 [PubMed - indexed for MEDLINE]Related articles

    4.

    Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism.

    Kowalska I, Straczkowski M, Szelachowska M, Kinalska I, Prokop J, Bachórzewska-Gajewska H, Stepien A.

    Metabolism. 2002 Jun;51(6):733-6.PMID: 12037726 [PubMed - indexed for MEDLINE]Related articles

    5.

    High serum concentrations of soluble E-selectin correlate with obesity but not fat distribution in patients with type 2 diabetes mellitus.

    Matsumoto K, Sera Y, Abe Y, Tominaga T, Horikami K, Hirao K, Ueki Y, Miyake S.

    Metabolism. 2002 Jul;51(7):932-4.PMID: 12077744 [PubMed - indexed for MEDLINE]Related articles

    6.

    Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control.

    Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti MG, Moghetti P, Lo Cascio V.

    Diabetologia. 1995 Sep;38(9):1122-4.PMID: 8591829 [PubMed - indexed for MEDLINE]Related articles

    7.

    Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus.

    Matsumoto K, Sera Y, Nakamura H, Ueki Y, Miyake S.

    Diabetes Res Clin Pract. 2002 Feb;55(2):131-8.PMID: 11796179 [PubMed - indexed for MEDLINE]Related articles

    8.

    E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress.

    Cominacini L, Fratta Pasini A, Garbin U, Campagnola M, Davoli A, Rigoni A, Zenti MG, Pastorino AM, Lo Cascio V.

    Diabetologia. 1997 May;40(5):584-9.PMID: 9165228 [PubMed - indexed for MEDLINE]Related articles

    9.

    Soluble E-selectin, leptin, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.

    Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Yamano G, Yanagawa T, Ohgushi M, Ohya M, Yoshii S, Taki Y, Seino Y.

    Metabolism. 2005 Mar;54(3):376-80.PMID: 15736116 [PubMed - indexed for MEDLINE]Related articles

    10.

    Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia.

    Marfella R, Esposito K, Giunta R, Coppola G, De Angelis L, Farzati B, Paolisso G, Giugliano D.

    Circulation. 2000 May 16;101(19):2247-51.PMID: 10811590 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes.

    Leinonen E, Hurt-Camejo E, Wiklund O, Hultén LM, Hiukka A, Taskinen MR.

    Atherosclerosis. 2003 Feb;166(2):387-94.PMID: 12535753 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients.

    Taniguchi A, Nakai Y, Sakai M, Yoshii S, Hamanaka D, Hatae Y, Kawata M, Yamanouchi K, Okumura T, Doi K, Tokuyama K, Nagasaka S, Fukushima M.

    Metabolism. 2002 May;51(5):544-8.PMID: 11979383 [PubMed - indexed for MEDLINE]Related articles

    13.

    Chronic low-dose lipid infusion in healthy patients induces markers of endothelial activation independent of its metabolic effects.

    Kashyap SR, Belfort R, Cersosimo E, Lee S, Cusi K.

    J Cardiometab Syndr. 2008 Summer;3(3):141-6.PMID: 18983329 [PubMed - indexed for MEDLINE]Related articles

    14.

    Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension.

    Boulbou MS, Koukoulis GN, Makri ED, Petinaki EA, Gourgoulianis KI, Germenis AE.

    Int J Cardiol. 2005 Jan;98(1):39-44.PMID: 15676164 [PubMed - indexed for MEDLINE]Related articles

    15.

    Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

    Meigs JB, Hu FB, Rifai N, Manson JE.

    JAMA. 2004 Apr 28;291(16):1978-86.PMID: 15113816 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Correction of hyperglycaemia reduces insulin resistance and serum soluble E-selectin levels in patients with Type 2 diabetes mellitus.

    Matsumoto K, Nakamura H, Ueki Y, Tominaga T, Miyake S.

    Diabet Med. 2001 Mar;18(3):224-8.PMID: 11318844 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

    Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E.

    Diabetes. 2001 Aug;50(8):1807-12.PMID: 11473042 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?

    Burén J, Lindmark S, Renström F, Eriksson JW.

    Metabolism. 2003 Feb;52(2):239-45.PMID: 12601640 [PubMed - indexed for MEDLINE]Related articles

    19.

    Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass.

    Fischer S, Hanefeld M, Haffner SM, Fusch C, Schwanebeck U, Köhler C, Fücker K, Julius U.

    Acta Diabetol. 2002 Sep;39(3):105-10.PMID: 12357293 [PubMed - indexed for MEDLINE]Related articles

    20.

    Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-selectin concentrations in type 2 diabetes.

    Ryysy L, Yki-Järvinen H.

    Diabetes Care. 2001 Mar;24(3):549-54.PMID: 11289483 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity